Palliative Systemic Therapy Given near the End of Life for Metastatic Non-Small Cell Lung Cancer

Background: The use of chemotherapy near end of life (EOL) for various cancers is increasing and has been shown to be associated with delayed access to palliative care (PC) and increased aggressiveness in EOL care, without any benefit on survival. Methods: This retrospective study included 90 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaudet, Marc-Étienne, Lacasse, Yves, Labbé, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947187/
https://www.ncbi.nlm.nih.gov/pubmed/35323312
http://dx.doi.org/10.3390/curroncol29030112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947187/
https://www.ncbi.nlm.nih.gov/pubmed/35323312
http://dx.doi.org/10.3390/curroncol29030112

Ejemplares similares